Artykuły w czasopismach na temat „Presentation of peptides”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Presentation of peptides”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wen, R., G. A. Cole, S. Surman, M. A. Blackman, and D. L. Woodland. "Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells." Journal of Experimental Medicine 183, no. 3 (1996): 1083–92. http://dx.doi.org/10.1084/jem.183.3.1083.
Pełny tekst źródłaUtz, U., S. Koenig, J. E. Coligan, and W. E. Biddison. "Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule." Journal of Immunology 149, no. 1 (1992): 214–21. http://dx.doi.org/10.4049/jimmunol.149.1.214.
Pełny tekst źródłaZandvliet, Maarten L., J. H. Frederik Falkenburg, Michel G. D. Kester, et al. "Sequence Dependent Efficiency of Cross-Presentation in MHC Class I Requires Rational Design of Long Synthetic Peptides for Vaccination or Ex Vivo Activation." Blood 112, no. 11 (2008): 3904. http://dx.doi.org/10.1182/blood.v112.11.3904.3904.
Pełny tekst źródłaNeisig, A., J. Roelse, A. J. Sijts, et al. "Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences." Journal of Immunology 154, no. 3 (1995): 1273–79. http://dx.doi.org/10.4049/jimmunol.154.3.1273.
Pełny tekst źródłaFremont, Daved H., Shaodong Dai, Herbert Chiang, Frances Crawford, Philippa Marrack, and John Kappler. "Structural Basis of Cytochrome c Presentation by IEk." Journal of Experimental Medicine 195, no. 8 (2002): 1043–52. http://dx.doi.org/10.1084/jem.20011971.
Pełny tekst źródłaHombach, J., H. Pircher, S. Tonegawa, and R. M. Zinkernagel. "Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein." Journal of Experimental Medicine 182, no. 5 (1995): 1615–19. http://dx.doi.org/10.1084/jem.182.5.1615.
Pełny tekst źródłaDaniel, Soizic, Vladimir Brusic, Sophie Caillat-Zucman, et al. "Relationship Between Peptide Selectivities of Human Transporters Associated with Antigen Processing and HLA Class I Molecules." Journal of Immunology 161, no. 2 (1998): 617–24. http://dx.doi.org/10.4049/jimmunol.161.2.617.
Pełny tekst źródłaMo, X. Y., Paolo Cascio, Kristen Lemerise, Alfred L. Goldberg, and Kenneth Rock. "Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides." Journal of Immunology 163, no. 11 (1999): 5851–59. http://dx.doi.org/10.4049/jimmunol.163.11.5851.
Pełny tekst źródłaMonji, T., and D. Pious. "Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells." Journal of Immunology 158, no. 7 (1997): 3155–64. http://dx.doi.org/10.4049/jimmunol.158.7.3155.
Pełny tekst źródłaStryhn, A., L. O. Pedersen, T. Romme, et al. "pH dependence of MHC class I-restricted peptide presentation." Journal of Immunology 156, no. 11 (1996): 4191–97. http://dx.doi.org/10.4049/jimmunol.156.11.4191.
Pełny tekst źródłaBoucau, Julie, Julien Madouasse, Christopher Carlin, et al. "Effect of cellular activation on the antigen processing machinery of primary CD4 T cells. (P5029)." Journal of Immunology 190, no. 1_Supplement (2013): 110.15. http://dx.doi.org/10.4049/jimmunol.190.supp.110.15.
Pełny tekst źródłaGarstka, Malgorzata A., Alexander Fish, Patrick H. N. Celie, et al. "The first step of peptide selection in antigen presentation by MHC class I molecules." Proceedings of the National Academy of Sciences 112, no. 5 (2015): 1505–10. http://dx.doi.org/10.1073/pnas.1416543112.
Pełny tekst źródłaYin, Liusong, Mauricio Calvo-Calle, and Lawrence Stern. "Characterization of HLA-DM susceptibility of MHC II-peptide complex in antigen presentation and epitope selection (100.54)." Journal of Immunology 186, no. 1_Supplement (2011): 100.54. http://dx.doi.org/10.4049/jimmunol.186.supp.100.54.
Pełny tekst źródłaAnton, L. C., J. W. Yewdell, and J. R. Bennink. "MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies." Journal of Immunology 158, no. 6 (1997): 2535–42. http://dx.doi.org/10.4049/jimmunol.158.6.2535.
Pełny tekst źródłaLegge, Kevin L., Booki Min, Christopher Pack, Jacque Caprio, and Habib Zaghouani. "Differential Presentation of an Altered Peptide Within Fetal Central and Peripheral Organs Supports an Avidity Model for Thymic T Cell Development and Implies a Peripheral Readjustment for Activation." Journal of Immunology 162, no. 10 (1999): 5738–46. http://dx.doi.org/10.4049/jimmunol.162.10.5738.
Pełny tekst źródłaBarouch, D., T. Friede, S. Stevanović, et al. "HLA-A2 subtypes are functionally distinct in peptide binding and presentation." Journal of Experimental Medicine 182, no. 6 (1995): 1847–56. http://dx.doi.org/10.1084/jem.182.6.1847.
Pełny tekst źródłaPrasad, Sharanya, Shelley Starck, and Nilabh Shastri. "Presentation of cryptic peptides by MHC I molecules is enhanced by inflammatory stimuli. (P5003)." Journal of Immunology 190, no. 1_Supplement (2013): 110.2. http://dx.doi.org/10.4049/jimmunol.190.supp.110.2.
Pełny tekst źródłaLind, Kristin, Hernando Escobar, Eduardo Reyes-Vargas, Julio Delgado, and Nilabh Shastri. "ERAAP-deficiency differentially affects peptide presentation across multiple MHC I (100.15)." Journal of Immunology 186, no. 1_Supplement (2011): 100.15. http://dx.doi.org/10.4049/jimmunol.186.supp.100.15.
Pełny tekst źródłaBacik, I., J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. "TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide." Journal of Immunology 152, no. 2 (1994): 381–87. http://dx.doi.org/10.4049/jimmunol.152.2.381.
Pełny tekst źródłaKhodadoust, Michael, Niclas Olsson, Lisa Wagar, et al. "Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens." Blood 128, no. 22 (2016): 915. http://dx.doi.org/10.1182/blood.v128.22.915.915.
Pełny tekst źródłaVijayasimha, Kartikeya, Amy Leigh Leestemaker-Palmer, James Gibb, Jonathan W. Yewdell, and Brian P. Dolan. "Targeted protein degradation via NEDD8 conjugation does not enhance direct MHC class I antigen presentation." Journal of Immunology 206, no. 1_Supplement (2021): 93.01. http://dx.doi.org/10.4049/jimmunol.206.supp.93.01.
Pełny tekst źródłaZajonc, Dirk M. "Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation." International Journal of Molecular Sciences 21, no. 20 (2020): 7561. http://dx.doi.org/10.3390/ijms21207561.
Pełny tekst źródłaLo-Man, Richard, Jan P. M. Langeveld, Pierre Martineau, Maurice Hofnung, Robert H. Meloen, and Claude Leclerc. "Immunodominance Does Not Result from Peptide Competition for MHC Class II Presentation." Journal of Immunology 160, no. 4 (1998): 1759–66. http://dx.doi.org/10.4049/jimmunol.160.4.1759.
Pełny tekst źródłaRimer, Jamie, and Emil Unanue. "Presentation of citrullinated peptides by class II histocompatibility molecules is associated with autophagy. (100.19)." Journal of Immunology 186, no. 1_Supplement (2011): 100.19. http://dx.doi.org/10.4049/jimmunol.186.supp.100.19.
Pełny tekst źródłaBalasubramani, Anand. "Stitching peptides for presentation." Science 362, no. 6412 (2018): 300.20–302. http://dx.doi.org/10.1126/science.362.6412.300-t.
Pełny tekst źródłaHeemels, Marie-Thérèse, and Hidde Ploegh. "Antigen presentation: Untapped peptides." Current Biology 3, no. 6 (1993): 380–83. http://dx.doi.org/10.1016/0960-9822(93)90208-6.
Pełny tekst źródłaBell, Elaine. "Trimming peptides for presentation." Nature Reviews Immunology 6, no. 1 (2006): 7. http://dx.doi.org/10.1038/nri1765.
Pełny tekst źródłaSamson Li, Chi Han, Hong Wang, Kin Tak Chan, et al. "Abstract 3538: The development of neoantigen-derived peptide vaccine driven by AI epitope design and computer assisted epitope enhancement." Cancer Research 85, no. 8_Supplement_1 (2025): 3538. https://doi.org/10.1158/1538-7445.am2025-3538.
Pełny tekst źródłaFox, Robert I., and Ho-Il Kang. "Mechanism of Action of Antimalarial Drugs: Inhibition of Antigen Processing and Presentation." Lupus 2, no. 1_suppl (1993): 9–12. http://dx.doi.org/10.1177/0961203393002001031.
Pełny tekst źródłaCram, Erik D., Ryan S. Simmons, Amy L. Palmer, William H. Hildebrand, Daniel D. Rockey, and Brian P. Dolan. "Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection." Infection and Immunity 84, no. 2 (2015): 480–90. http://dx.doi.org/10.1128/iai.01254-15.
Pełny tekst źródłaShawar, S. M., J. M. Vyas, E. Shen, J. R. Rodgers, and R. R. Rich. "Differential amino-terminal anchors for peptide binding to H-2M3a or H-2Kb and H-2Db." Journal of Immunology 151, no. 1 (1993): 201–10. http://dx.doi.org/10.4049/jimmunol.151.1.201.
Pełny tekst źródłaLegge, Kevin L., Booki Min, Nicholas T. Potter, and Habib Zaghouani. "Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing." Journal of Experimental Medicine 185, no. 6 (1997): 1043–54. http://dx.doi.org/10.1084/jem.185.6.1043.
Pełny tekst źródłavan Ham, Marieke, Marcel van Lith, Björn Lillemeier, et al. "Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do." Journal of Experimental Medicine 191, no. 7 (2000): 1127–36. http://dx.doi.org/10.1084/jem.191.7.1127.
Pełny tekst źródłaSorvillo, Nicoletta, Simon D. van Haren, Paul H. Kaijen, et al. "Preferential HLA-DRB1*11 Dependent Presentation of CUB2 Derived Peptides by ADAMTS13 Pulsed Dendritic Cells." Blood 120, no. 21 (2012): 489. http://dx.doi.org/10.1182/blood.v120.21.489.489.
Pełny tekst źródłaChen, B. P., A. Madrigal, and P. Parham. "Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule." Journal of Experimental Medicine 172, no. 3 (1990): 779–88. http://dx.doi.org/10.1084/jem.172.3.779.
Pełny tekst źródłaNagamine, Brandy S., and Brian P. Dolan. "The unfolded protein response alters MHC class I antigen presentation in a mouse cell line." Journal of Immunology 200, no. 1_Supplement (2018): 99.9. http://dx.doi.org/10.4049/jimmunol.200.supp.99.9.
Pełny tekst źródłaGarg, Manish, Margaret K. Callahan, and Pramod K. Srivastava. "Essential role of heat shock protein 90 in direct and cross-presentation (93.13)." Journal of Immunology 178, no. 1_Supplement (2007): S168. http://dx.doi.org/10.4049/jimmunol.178.supp.93.13.
Pełny tekst źródłaLee, Daniel, Andy J. Minn, and Lexus R. Johnson. "CAR-T cells to deliver engineered peptide antigens and reprogram antigen specific T cell responses against solid tumors." Journal of Clinical Oncology 39, no. 15_suppl (2021): 2530. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.2530.
Pełny tekst źródłaHall, Pamela R., Brian Hjelle, David C. Brown, et al. "Multivalent Presentation of Antihantavirus Peptides on Nanoparticles Enhances Infection Blockade." Antimicrobial Agents and Chemotherapy 52, no. 6 (2008): 2079–88. http://dx.doi.org/10.1128/aac.01415-07.
Pełny tekst źródłaRosloniec, E. F., L. J. Vitez, S. Buus, and J. H. Freed. "MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation." Journal of Experimental Medicine 171, no. 5 (1990): 1419–30. http://dx.doi.org/10.1084/jem.171.5.1419.
Pełny tekst źródłaAdorini, L., J. Moreno, F. Momburg, et al. "Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells." Journal of Experimental Medicine 174, no. 4 (1991): 945–48. http://dx.doi.org/10.1084/jem.174.4.945.
Pełny tekst źródłaHaque, Syed Mahdee, Abdul-Rahman Salman, Hamdi Abdeen, et al. "Cancer immunotherapy: Identifying cancer testis antigen peptides to enhance antitumor response." Journal of Clinical Oncology 40, no. 16_suppl (2022): e20022-e20022. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e20022.
Pełny tekst źródłaMellins, E., P. Cameron, M. Amaya, et al. "A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides." Journal of Experimental Medicine 179, no. 2 (1994): 541–49. http://dx.doi.org/10.1084/jem.179.2.541.
Pełny tekst źródłaDörfel, Daniela, Silke Appel, Frank Grünebach, et al. "Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA." Blood 105, no. 8 (2005): 3199–205. http://dx.doi.org/10.1182/blood-2004-09-3556.
Pełny tekst źródłaLazarski, Christopher A., Francisco A. Chaves, and Andrea J. Sant. "The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability." Journal of Experimental Medicine 203, no. 5 (2006): 1319–28. http://dx.doi.org/10.1084/jem.20060058.
Pełny tekst źródłaMa, Yue, and Yoko Yamakoshi. "(Invited, Digital Presentation) Aggregation Switchable Fullerene-Peptides Conjugates." ECS Meeting Abstracts MA2022-01, no. 11 (2022): 810. http://dx.doi.org/10.1149/ma2022-0111810mtgabs.
Pełny tekst źródłavan Ham, S. M., U. Grüneberg, G. Malcherek, I. Bröker, A. Melms, and J. Trowsdale. "Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs." Journal of Experimental Medicine 184, no. 5 (1996): 2019–24. http://dx.doi.org/10.1084/jem.184.5.2019.
Pełny tekst źródłaKropp, Laura, Manish Garg, and Robert Binder. "Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC I in the endoplasmic reticulum (130.26)." Journal of Immunology 184, no. 1_Supplement (2010): 130.26. http://dx.doi.org/10.4049/jimmunol.184.supp.130.26.
Pełny tekst źródłaShimojo, N., W. L. Maloy, R. W. Anderson, W. E. Biddison, and J. E. Coligan. "Specificity of peptide binding by the HLA-A2.1 molecule." Journal of Immunology 143, no. 9 (1989): 2939–47. http://dx.doi.org/10.4049/jimmunol.143.9.2939.
Pełny tekst źródłaZügel, U., B. Schoel, and S. H. Kaufmann. "Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone." Journal of Immunology 153, no. 9 (1994): 4070–80. http://dx.doi.org/10.4049/jimmunol.153.9.4070.
Pełny tekst źródła